Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  midostaurin
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 60
Trial IDs: CPKC412AUS23, NCI-2013-02275, NCT01883362
Midostaurin and Decitabine in Treating Older Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: MC1483, NCI-2015-02107, NCT02634827
Midostaurin in Treating Older Patients with Mutated Acute Myeloid Leukemia Post-Transplant
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: HEMAML0022-EXT, NCI-2016-00424, NCT02723435
Chemotherapy, Radiation Therapy, and Midostaurin in Treating Patients with Locally Advanced Rectal Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 10-457, NCI-2011-03089, CPKC412AUS09T, NCT01282502
Start Over